METABOLIC EFFECTS OF A CHANGE IN ANTIHYPERTENSIVE TREATMENT

被引：9

作者：

LITHELL, H ^{[1
]}

ABERG, H ^{[1
]}

SELINUS, I ^{[1
]}

机构：

[1] UNIV UPPSALA, DEPT FAMILY MED, S-75012 UPPSALA, SWEDEN

来源：

AMERICAN JOURNAL OF MEDICINE | 1986年 / 80卷 / 2A期

关键词：

D O I：

10.1016/0002-9343(86)90170-1

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：114 / 119

页数：6

共 45 条

[1]

ABERG H, 1980, ACTA MED SCAND, V208, P467

[2]

AMERY A, 1978, LANCET, V1, P681

[3] IMPROVEMENT OF GLUCOSE-TOLERANCE AND LOWERING OF GLYCOHEMOGLOBIN AND SERUM-LIPID CONCENTRATIONS AFTER DISCONTINUATION OF ANTIHYPERTENSIVE DRUG-THERAPY [J].

AMES, RP ;

HILL, P .

CIRCULATION, 1982, 65 (05) :899-904

[4] EFFECTS OF TREATMENT ON MORBIDITY IN HYPERTENSION - RESULTS IN PATIENTS WITH DIASTOLIC BLOOD PRESSURES AVERAGING 115 THROUGH 129 MM HG [J].

不详 .

JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1967, 202 (11) :1028-&

[5]

[Anonymous], 1981, LANCET, V2, P539

[6]

[Anonymous], 1980, LANCET, V1, P1261

[7] METABOLIC EFFECTS OF PRAZOSIN [J].

BARBIERI, C ;

CALDARA, R ;

FERRARI, C ;

DALBO, GA ;

PARACCHI, A ;

ROMUSSI, M ;

CURTARELLI, G .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1980, 27 (03) :313-316

[8] METABOLIC EFFECTS OF CHRONIC PRAZOSIN TREATMENT [J].

BARBIERI, C ;

FERRARI, C ;

BORZIO, M ;

PIEPOLI, V ;

CALDARA, R .

HORMONE AND METABOLIC RESEARCH, 1980, 12 (07) :331-334

[9]

BERGLUND G, 1978, LANCET, V1, P1

[10] HDL CHOLESTEROL AND OTHER LIPIDS IN CORONARY HEART-DISEASE - COOPERATIVE LIPOPROTEIN PHENOTYPING STUDY [J].

CASTELLI, WP ;

DOYLE, JT ;

GORDON, T ;

HAMES, CG ;

HJORTLAND, MC ;

HULLEY, SB ;

KAGAN, A ;

ZUKEL, WJ .

CIRCULATION, 1977, 55 (05) :767-772

← 1 2 3 4 5 →